Morris Capital Advisors, LLC Biogen Inc. Transaction History

Morris Capital Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 19, 2021	SELL	$236.26 - $355.63 $379,433 - $571,141	-1,606 Closed	0 $0
Q3 2020 Oct 19, 2020	SELL	$264.77 - $305.71 $12,708 - $14,674	-48 Reduced 2.9%	1,606 $456,000
Q2 2020 Jul 23, 2020	SELL	$258.66 - $342.55 $424,202 - $561,782	-1,640 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$268.85 - $341.04 $9,947 - $12,618	-37 Reduced 2.21%	1,640 $519,000
Q4 2019 Jan 31, 2020	SELL	$220.06 - $304.07 $8,362 - $11,554	-38 Reduced 2.22%	1,677 $498,000
Q1 2019 Apr 29, 2019	SELL	$216.71 - $338.96 $1,950 - $3,050	-9 Reduced 0.52%	1,715 $405,000
Q4 2018 Feb 20, 2019	SELL	$278.5 - $352.75 $17,267 - $21,870	-62 Reduced 3.47%	1,724 $519,000
Q3 2018 Oct 31, 2018	SELL	$293.51 - $383.83 $11,740 - $15,353	-40 Reduced 2.19%	1,786 $631,000
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $5,202 - $7,358	20 Added 1.11%	1,826 $500,000
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $1,230 - $1,378	4 Added 0.22%	1,806 $575,000
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $506,632 - $594,101	1,802	1,802 $564,000

1,004

129M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Morris Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Morris Capital Advisors, LLC with notifications on news.